1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

  • September 2016
  • 156 pages
  • ID: 4143835
  • Format: PDF
  • By BCC Research


Table of Contents

Use this report to:
- Analyze the global market for antithrombotic/anticoagulant drugs and the different segments for treating thrombotic disease.
- View competitive analyses of recent developments and current trends in the developed global antithrombotic/anticoagulant drugs market.
- Evaluate valuable resources in the operations of pharmacy and, more specifically, automated pharmacy processes.
- Discuss the major players in each of the regional markets and explain the global drivers, current products, challenges and regional dynamics of the market.

- The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016, a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021.
- The North American antithrombotic/anticoagulant drugs market is expected to grow from nearly $8.0 billion in 2016 to nearly $11.0 billion in 2021, a CAGR of 6.6% for the period 2016-2021.
- The antithrombotic/anticoagulant drugs market in Asia-Pacific region is expected to grow from $3.7 billion in 2016 to roughly $6.3 billion in 2021, a CAGR of 11.2% for the period 2016-2021.

Introduction & Scope


The objectives of the study are to present a comprehensive look at antithrombotic/anticoagulant drugs for treating thrombotic disease, quantify the global market for these drugs and its market segments, and forecast market and segment growth over the next five years.

This BCC Research study is presented to increase the awareness of antithrombotic/anticoagulant drugs to treat thrombotic disease and other diseases that
are linked to thrombotic disease. The study analyzes (1) select antithrombotic/anticoagulant drugs for treating various thrombotic diseases in coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; (2) the marketing of these drugs in the global market from different standpoints; and (3) the issues and trends affecting the market.

Antithrombotic/anticoagulant manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of products. Because of the evolving nature of this important area of study, executives of product development for antithrombotic/anticoagulant drugs must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of the market.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The
geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.

Categories discussed in the report include:
- Anticoagulants.
- Antiplatelets.
- Thrombin inhibitors.
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2016 to 2021 and assessing the competitors their market shares.

The information and analysis presented in this BCC Research report are based on extensive first-hand interviews with primary research sources, including executives,
product managers and clinical specialists in the congestive heart failure drug development space. Background information was obtained from various government
agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the treatment of thrombotic and cardiovascular disease.

Key information from published literature was used to conduct interviews with more than 12 industry participants to validate and obtain expert opinions on current and future trends in the antithrombotic/anticoagulant drug market. Interviews were the primary source of information used to assess market size and were conducted via email and telephone. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data pertain to the global market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year was 2016. Historical data are provided for 2015 and forecast data are provided for 2021. Historical, base year and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2014 base year.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Cardiovascular Drugs Industry

Global Cardiovascular Drugs Industry

  • $ 5450
  • October 2019

Cardiovascular Drugs market worldwide is projected to grow by US$7.8 Billion, driven by a compounded growth of 1.4%. Renin-Angiotensin System Blockers, one of the segments analyzed and sized in this study, ...

Optic Neuropathy - Pipeline Review, H2 2019

Optic Neuropathy - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Optic Neuropathy - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Optic Neuropathy - Pipeline Review, H2 2019, provides an overview of the Optic Neuropathy ...

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

MAP Kinase Interacting Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’MAP Kinase Interacting SerineThreonine Protein Kinase 2 - Pipeline ...


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on